Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors

Marco Artini(Fondazione Andrea Cesalpino), C. Balsam(University of L'Aquila), G. Girelli(Sapienza University of Rome), M Caratozzolo(Sapienza University of Rome), Lorenzo Pietropaolo(Nini Hospital), Antonio Costanzo(Humanitas University), Massimo Levrero(Northwest Medical Specialties), Elisabetta Cariani(University of Parma), Giuseppe Montalto(University of Palermo), F. Grimaldi(Policlinico Umberto I), Angelo Rossini(Centro Universitário Barão de Mauá), Gilda Stivali(Fondazione Andrea Cesalpino), M. Fulco(Fondazione Andrea Cesalpino), C. Almerighi(Sapienza University of Rome)
Digestive and Liver Disease
August 1, 2002
10.1016/s1590-8658(02)80090-1
Cited by 5

Related Papers

Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
|Aging|2011|707
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials
|British Journal of Dermatology|2020|389
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
|Oncotarget|2012|317